Coeptis Therapeutics Correlations
COEPW Stock | USD 0.02 0.00 0.00% |
The current 90-days correlation between Coeptis Therapeutics and Coeptis Therapeutics is 0.02 (i.e., Significant diversification). The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Coeptis Therapeutics Correlation With Market
Good diversification
The correlation between Coeptis Therapeutics Holdings and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Coeptis Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.
Coeptis |
Moving against Coeptis Stock
0.49 | MTEM | Molecular Templates | PairCorr |
0.48 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.45 | TPST | Tempest Therapeutics | PairCorr |
0.44 | ME | 23Andme Holding | PairCorr |
0.39 | A | Agilent Technologies | PairCorr |
0.38 | NKTX | Nkarta Inc | PairCorr |
0.37 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.36 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.35 | AGL | agilon health Buyout Trend | PairCorr |
0.32 | IPSC | Century Therapeutics | PairCorr |
0.63 | PG | Procter Gamble | PairCorr |
0.57 | KO | Coca Cola Aggressive Push | PairCorr |
0.56 | TLK | Telkom Indonesia Tbk | PairCorr |
0.53 | HYMTF | Hyundai Motor | PairCorr |
0.44 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.43 | EC | Ecopetrol SA ADR | PairCorr |
0.42 | WF | Woori Financial Group | PairCorr |
0.38 | SHG | Shinhan Financial | PairCorr |
0.34 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
0.33 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
0.0 | -0.15 | 0.16 | -0.16 | COEP | ||
0.0 | 0.28 | -0.08 | 0.31 | CMRAW | ||
-0.15 | 0.28 | -0.17 | 0.81 | ICUCW | ||
0.16 | -0.08 | -0.17 | 0.0 | CDIOW | ||
-0.16 | 0.31 | 0.81 | 0.0 | GRNAW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Coeptis Stock performing well and Coeptis Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Coeptis Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
COEP | 2.62 | (0.16) | (0.02) | (0.01) | 3.07 | 6.25 | 19.81 | |||
CMRAW | 14.32 | 2.25 | 0.09 | (0.43) | 15.21 | 51.52 | 104.14 | |||
ICUCW | 7.97 | 0.12 | (0.01) | (0.03) | 11.43 | 20.75 | 86.24 | |||
CDIOW | 11.86 | 0.38 | 0.04 | 0.23 | 13.34 | 32.01 | 76.02 | |||
GRNAW | 12.98 | (0.49) | (0.01) | 0.00 | 14.82 | 32.45 | 85.19 |
Coeptis Therapeutics Corporate Management
Christine Sheehy | CFO CoFounder | Profile | |
Daniel Yerace | VP CoFounder | Profile | |
Gary Conte | VP Marketing | Profile | |
David Mehalick | Chairman, CoFounder | Profile |